KR Kroger Company

$66.07

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending 2025-10-31
Expected on Nov 27, 2025
Report Time: Unknown Release Time
The Whisper Number
$1.06
Consensus Estimate: $1.03
Revenue Estimate: $34.28B

Latest Earnings Insight

Kroger's strategic focus on enhancing customer experience and operational efficiency has been paying off, as evidenced by its robust second-quarter 2025 performance, which led to an upward revision of its full-year guidance. As the company gears up for its upcoming earnings release on November 27, 2025, analysts are eyeing an EPS estimate of $1.03 and a revenue estimate of $34.28 billion. However, the whisper number suggests a slightly more optimistic EPS of $1.06, reflecting market confidence in Kroger's ability to exceed expectations. With a market cap of approximately $44.2 billion, Kroger has demonstrated resilience in a challenging retail environment, bolstered by a 3.4% increase in identical sales and a remarkable 16% growth in eCommerce sales during the second quarter. This growth trajectory, coupled with strategic initiatives such as simplifying operations and focusing on value-driven shoppers, positions Kroger well to continue its momentum, potentially leading to another earnings beat.

Updated On 11/21/2025

About Kroger Company

The Kroger Company, or simply Kroger, is an American retail company founded by Bernard Kroger in 1883 in Cincinnati, Ohio.

Website: https://www.thekrogerco.com

Sector
TRADE & SERVICES
Industry
RETAIL-GROCERY STORES
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
January
CIK
56873
Address
1014 VINE ST, CINCINNATI, OH, US
Valuation
Market Cap
$47.07B
P/E Ratio
19.41
PEG Ratio
1.72
Price to Book
5.68
Performance
EPS
$3.67
Dividend Yield
1.80%
Profit Margin
1.81%
ROE
26.90%
Technicals
50D MA
$65.99
200D MA
$59.13
52W High
$71.93
52W Low
$48.24
Fundamentals
Shares Outstanding
661M
Target Price
$67.64
Beta
0.59

KR EPS Estimates vs Actual

Estimated
Actual

KR News & Sentiment

Nov 21, 2025 • Zacks Commentary BULLISH
WMT Stock Up 6.5% on Solid Q3 & Upbeat View: Time to Buy or Hold?
Walmart jumps 6.5% after a strong Q3 and a raised fiscal 2026 outlook, with e-commerce, membership and advertising fueling momentum.
Nov 20, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Here's Why Kroger ( KR ) Fell More Than Broader Market
The latest trading day saw Kroger (KR) settling at $65.9, representing a -2.24% change from its previous close.
Nov 20, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Walmart ( WMT ) Q3 Earnings and Revenues Top Estimates
Walmart (WMT) delivered earnings and revenue surprises of +1.64% and +1.33%, respectively, for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 19, 2025 • Benzinga NEUTRAL
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. ( NASDAQ: CYTK ) ; Fortrea Holdings, Inc. ( NASDAQ: FTRE ) ; Ibotta, Inc. ( NYSE: IBTA ) ; and Stride, Inc. ( NYSE: LRN ) : Grabar Law Office is Investigating Claims on Your Behalf - Fortrea Holdings ( NASDAQ:FTRE ) , Cytokinetics ( NASDAQ:CYTK )
PHILADELPHIA, Nov. 19, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. ( NASDAQ:CYTK ) . The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Nov 18, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is Kroger ( KR ) a Buy as Wall Street Analysts Look Optimistic?
Based on the average brokerage recommendation (ABR), Kroger (KR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Nov 18, 2025 • Benzinga NEUTRAL
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. ( NASDAQ: CYTK ) ; enCore Energy Corp. ( NASDAQ: EU ) ; Fluor Corporation ( NYSE: FLR ) ; Fortrea Holdings, Inc. ( NASDAQ: FTRE ) ; and Ibotta, Inc. ( NYSE: IBTA ) : Grabar Law Office is Investigating Claims on Your Behalf - enCore Energy ( NASDAQ:EU ) , Cytokinetics ( NASDAQ:CYTK )
PHILADELPHIA, Nov. 18, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. ( NASDAQ:CYTK ) . The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Sentiment Snapshot

Average Sentiment Score:

0.281
50 articles with scored sentiment

Overall Sentiment:

Bullish

KR Reported Earnings

Sep 11, 2025
Jul 31, 2025 (Pre market)
0.04 Surprise
  • Reported EPS: $1.04
  • Estimate: $1.00
  • Whisper:
  • Surprise %: 4.0%
Jun 20, 2025
Apr 30, 2025 (Pre market)
0.03 Surprise
  • Reported EPS: $1.49
  • Estimate: $1.46
  • Whisper:
  • Surprise %: 2.0%
Mar 06, 2025
Jan 31, 2025 (Pre market)
0.03 Surprise
  • Reported EPS: $1.14
  • Estimate: $1.11
  • Whisper:
  • Surprise %: 2.7%
Dec 05, 2024
Oct 31, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $0.98
  • Estimate: $0.98
  • Whisper:
  • Surprise %: 0.0%
Sep 12, 2024
Jul 31, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.93
  • Estimate: $0.91
  • Whisper:
  • Surprise %: 2.2%
Jun 20, 2024
Apr 30, 2024 (Pre market)
0.09 Surprise
  • Reported EPS: $1.43
  • Estimate: $1.34
  • Whisper:
  • Surprise %: 6.7%
Mar 07, 2024
Jan 31, 2024 (Pre market)
0.21 Surprise
  • Reported EPS: $1.34
  • Estimate: $1.13
  • Whisper:
  • Surprise %: 18.6%
Nov 30, 2023
Oct 31, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $0.95
  • Estimate: $0.90
  • Whisper:
  • Surprise %: 5.6%
Sep 08, 2023
Jul 31, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $0.96
  • Estimate: $0.91
  • Whisper:
  • Surprise %: 5.5%

Financials